The eyes have it
Dr Michelle Tempest and Patrick Bansch of bespoke health and social care strategy and investment consultancy Candesic get a close-up look of the private...
Clearing the mist on cataract surgery
With demand for cataract surgery on the rise, it is little wonder that some CCGs are looking to restrict access by introducing ‘visual acuity’...
The DOLLAR$ in DIALYSIS
The dialysis market is highly consolidated but is there room for growth? Sam Coates, Gonçalo Silva and Dr Victor Chua of Mansfield Advisors assess...
Unlocking the potential of In Vitro Diagnostics
In Vitro Diagnostics is gaining the attention of pharma companies and health systems across the globe as new technology paves the way for early...
Alternative funding for imaging equipment
As the NHS continues to raid capital budgets to continue delivering essential services, it is not just buildings but vital equipment that is falling...
Have baby, will travel
Despite huge medical advances over recent years, national policy on funding and access to fertility treatment varies widely from country to country. As regulation...
Safety dominates debate at Private Healthcare Summit
Key stakeholders from across independent healthcare gathered in London this week for the Private Healthcare Summit, which was set against a backdrop of increased...
IVF – fertile ground for consolidation?
Despite recent private equity interest, IVF and fertility treatment remains a highly fragmented market but that could be about to change. Dr Leonid Shapiro,...
A fair deal for would-be parents
English clinical commissioning groups (CCGs) are continuing to reduce the number of IVF treatment cycles they fund. How is this affecting demand for self-funded...
IVF – a boom ahead?
The UK fertility market is set to grow by 3% a year, and with rates per female population below many of its European neighbours...
©2025 All rights reserved LaingBuisson 